Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.
Young Joo LeeYoon Kyung ShinNae Ry KimSe Ik KimYoo Young LeeJeong-Yeol ParkJae-Weon KimHyun Woong ChoJung-Yun LeePublished in: Journal of gynecologic oncology (2024)
mutations and those receiving frontline maintenance therapy.